Src inhibition impairs LD formation by activating PPARγ-induced FABP4 expression and elevating reactive oxygen species (ROS) production, suggesting the critical role in Src/PPARγ/FABP4 axis in tumor proliferation (Hua et al., 2019). This evidence concerns the gene FABP4 and neoplasm.